Table Of Contents OLO INC. Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) (in thousands, except share and share data) Redeemable Convertible Preferred Stock Class A and Class B Common Stock Additional Paid In Capital Accumulated Deficit Total Stockholders' Equity (Deficit) Shares Amount Shares Amount Balance as of December 31, 2021 — $ — 157,700,189 $ 158 $ 813,166 $ (111,574) $ 701,750 Issuance of common stock on exercise of stock options — — 1,851,334 2 2,305 — 2,307 Vesting of restricted stock units — — 136,662 — — — — Stock-based compensation — — — — 12,457 — 12,457 Net loss — — — — — (11,509) (11,509) Balance as of Mar ch 31, 2022 — $ — 159,688,185 $ 160 $ 827,928 $ (123,083) $ 705,005 Redeemable Convertible Preferred Stock Class A and Class B Common Stock Additional Paid In Capital Accumulated Deficit Total Stockholders' Equity (Deficit) Shares Amount Shares Amount Balance as of December 31, 2020 58,962,749 $ 111,737 22,320,286 $ 22 $ 16,798 $ (69,301) $ (52,481) Initial public of fering, net of underwriting discount and deferred of fering costs — — 20,700,000 21 477,805 — 477,826 Accretion of redeemable convertible preferred stock to redemption value — 14 — — (14) — (14) Issuance of preferred stock on exercise of warrants 1,681,848 2 — — 39,056 — 39,056 Conversion of redeemable convertible preferred stock to common stock upon initial public of fering (60,644,597) (111,753) 100,196,780 100 111,653 — 111,753 Issuance of common stock upon settlement of Share Appreciation Rights — — 1,642,570 2 2,845 — 2,847 Issuance of common stock in connection with charitable donation — — 172,918 — 5,125 — 5,125 Issuance of common stock on exercise of stock options — — 1,965,824 2 2,155 — 2,157 Stock-based compensation — — — — 5,426 — 5,426 Net loss — — — — — (26,457) (26,457) Balance as of Mar ch 31, 2021 — $ — 146,998,378 $ 147 $ 660,849 $ (95,758) $ 565,238 The accompanying notes are an integral part of these financial statements. 3

Q1 2022 10Q - Page 7 Q1 2022 10Q Page 6 Page 8